ALPS Medical Breakthroughs ETF Rating $63.77 -0.56 (-0.87%) As of 07/24/2026 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsShort InterestBuy This Stock ALPS Medical Breakthroughs ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.SBIO Aggregate RatingModerate Buy 2.73Holdings in SBIO have an aggregate rating of Moderate Buy based on 339 analyst ratings issued in the past year covering 25 companies (57.0% of the portfolio).SBIO Aggregate Price Target$63.77High Prediction$63.77Average Prediction$63.77Low Prediction$63.77Holdings in SBIO have an aggregate price target of $63.77 and a range of $63.77 to $63.77 covering 25 companies (57.0% of the portfolio).SBIO Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy3 Buy rating(s)Moderate Buy19 Moderate Buy rating(s)Hold3 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by ALPS Medical Breakthroughs ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 SBIO Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings4.65%CRNXCrinetics Pharmaceuticals$83.73+0.1%2.2407 of 5 stars2.29$78.27 -6.5%17Short Interest Decrease4.36%APGEApogee Therapeutics$134.28+0.0%1.93 of 5 stars2.24$121.25 -9.7%21Positive News3.47%XENEXenon Pharmaceuticals$65.422.7717 of 5 stars3.00$77.20 18.0%17News CoveragePositive News3.33%CGONCG Oncology$69.32-2.5%3.3518 of 5 stars2.71$81.73 17.9%143.03%DNTHDianthus Therapeutics$103.87-0.9%2.2903 of 5 stars2.93$117.82 13.4%14News CoveragePositive News2.94%ORKAOruka Therapeutics$92.16+0.2%3.6282 of 5 stars2.82$134.30 45.7%11News CoveragePositive News2.77%TVTXTravere Therapeutics$57.36+1.2%1.9176 of 5 stars2.69$52.08 -9.2%13News CoveragePositive News2.54%DFTXDefinium Therapeutics$43.17+0.6%3.0413 of 5 stars3.00$51.15 18.5%17Analyst ForecastGap Up2.44%MANEVeradermics$109.82-5.2%2.7292 of 5 stars2.67$153.00 39.3%92.30%ACADACADIA Pharmaceuticals$24.84+0.0%4.6931 of 5 stars2.67$33.17 33.5%18Positive NewsAnalyst Forecast2.28%RLAYRelay Therapeutics$18.44-3.4%2.9569 of 5 stars2.86$24.92 35.1%14News CoverageAnalyst Forecast2.25%EWTXEdgewise Therapeutics$40.84+3.9%3.3625 of 5 stars2.82$48.75 19.4%11Positive News2.06%DYNDyne Therapeutics$24.44+2.3%3.3037 of 5 stars2.87$34.17 39.8%15Upcoming EarningsAnalyst Forecast1.95%NAMSNewAmsterdam Pharma$29.64-3.0%2.9074 of 5 stars2.93$49.42 66.7%14News CoveragePositive News1.94%DNLIDenali Therapeutics$23.11-1.3%2.6051 of 5 stars2.82$35.17 52.2%17News CoverageAnalyst Forecast1.81%GPCRStructure Therapeutics$49.12-3.3%2.3015 of 5 stars2.89$110.55 125.1%18News CoveragePositive News1.66%IDYAIDEAYA Biosciences$35.40-2.3%3.8509 of 5 stars2.81$50.25 41.9%161.57%MBXMBX Biosciences$62.00-2.5%1.7361 of 5 stars2.75$66.75 7.7%12News CoverageAnalyst Forecast1.53%IRONDisc Medicine$74.12-2.3%2.0545 of 5 stars2.73$104.44 40.9%111.46%CLDXCelldex Therapeutics$35.28-0.4%2.3142 of 5 stars2.86$52.77 49.6%14News CoverageAnalyst Forecast1.45%VERAVera Therapeutics$35.45-2.5%3.7164 of 5 stars2.77$84.58 138.6%13Positive News1.35%TARSTarsus Pharmaceuticals$58.66+0.1%3.287 of 5 stars2.78$90.50 54.3%9Analyst Forecast1.33%IMNMImmunome$22.21+0.9%3.2469 of 5 stars2.86$33.17 49.3%14News CoverageAnalyst Forecast1.29%SLSSELLAS Life Sciences Group$11.32-8.3%1.0466 of 5 stars2.33$10.00 -11.7%31.26%KLRAKailera Therapeutics$17.69+1.7%2.9544 of 5 stars3.00$42.75 141.7%7 This page (NYSEARCA:SBIO) was last updated on 7/25/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredSPCX Warning - and Worst News for Stocks in 50 YearsGoldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...TradeSmith | SponsoredElon's new "super startup"Adam O'Dell - the analyst who recommended Palantir before it became the top S&P 500 performer - has identified...Banyan Hill Publishing | SponsoredWhere to Put $100 Before Trump's New Tech Law Rolls OutThe Financial Times says a new tech law puts America 'on the verge of a financial revolution.' Yahoo Finance e...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ALPS Medical Breakthroughs ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share ALPS Medical Breakthroughs ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SBIO Stock Alerts